Literature DB >> 4444030

Rifamycins: an insight into biological activity based on structural investigations.

M Brufani, S Cerrini, W Fedeli, A Vaciago.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4444030     DOI： 10.1016/0022-2836(74)90094-1

Source DB:  PubMed          Journal:  J Mol Biol        ISSN： 0022-2836            Impact factor:   5.469


× No keyword cloud information.
  5 in total

1.  Inactivation of rifampin by Nocardia brasiliensis.

Authors:  K Yazawa; Y Mikami; A Maeda; M Akao; N Morisaki; S Iwasaki
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

Review 2.  Mechanistic aspects of promoter binding and chain initiation by RNA polymerase.

Authors:  C W Wu; N Tweedy
Journal:  Mol Cell Biochem       Date:  1982-09-17       Impact factor: 3.396

3.  Conformational variety for the ansa chain of rifamycins: comparison of observed crystal structures and molecular dynamics simulations.

Authors:  A Bacchi; G Pelizzi
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

4.  The antibiotic sorangicin A inhibits promoter DNA unwinding in a Mycobacterium tuberculosis rifampicin-resistant RNA polymerase.

Authors:  Mirjana Lilic; James Chen; Hande Boyaci; Nathaniel Braffman; Elizabeth A Hubin; Jennifer Herrmann; Rolf Müller; Rachel Mooney; Robert Landick; Seth A Darst; Elizabeth A Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-16       Impact factor: 11.205

5.  Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.

Authors:  James Peek; Mirjana Lilic; Daniel Montiel; Aleksandr Milshteyn; Ian Woodworth; John B Biggins; Melinda A Ternei; Paula Y Calle; Michael Danziger; Thulasi Warrier; Kohta Saito; Nathaniel Braffman; Allison Fay; Michael S Glickman; Seth A Darst; Elizabeth A Campbell; Sean F Brady
Journal:  Nat Commun       Date:  2018-10-08       Impact factor: 14.919
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.